Nu Skin Enterprises, Inc. (NUS) Scheduled to Post Quarterly Earnings on Wednesday

Nu Skin Enterprises, Inc. (NYSE:NUS) is scheduled to be announcing its earnings results after the market closes on Wednesday, November 1st. Analysts expect the company to announce earnings of $0.95 per share for the quarter. Nu Skin Enterprises has set its Q3 guidance at $0.71-0.76 EPS and its FY17 guidance at $3.20-3.30 EPS.

Nu Skin Enterprises (NYSE:NUS) last announced its earnings results on Wednesday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.69 by $0.08. The business had revenue of $550.10 million for the quarter, compared to analyst estimates of $548.09 million. Nu Skin Enterprises had a return on equity of 24.14% and a net margin of 7.53%. Nu Skin Enterprises’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.79 EPS. On average, analysts expect Nu Skin Enterprises to post $3.24 EPS for the current fiscal year and $3.42 EPS for the next fiscal year.

Nu Skin Enterprises, Inc. (NYSE NUS) opened at 63.42 on Monday. Nu Skin Enterprises, Inc. has a 52-week low of $46.35 and a 52-week high of $65.85. The firm’s 50 day moving average price is $62.31 and its 200 day moving average price is $59.93. The firm has a market cap of $3.36 billion, a price-to-earnings ratio of 21.21 and a beta of 1.40.

ILLEGAL ACTIVITY WARNING: This article was originally published by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.com-unik.info/2017/10/30/nu-skin-enterprises-inc-nus-scheduled-to-post-quarterly-earnings-on-wednesday.html.

NUS has been the topic of several recent research reports. Stifel Nicolaus set a $50.00 price target on Nu Skin Enterprises and gave the stock a “sell” rating in a report on Thursday, August 3rd. Zacks Investment Research downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Thursday, October 5th. Bank of America Corporation increased their price objective on Nu Skin Enterprises from $53.00 to $57.00 and gave the stock an “underperform” rating in a research note on Monday, July 10th. BidaskClub downgraded Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Finally, TheStreet raised Nu Skin Enterprises from a “c+” rating to a “b” rating in a research note on Wednesday, August 2nd. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $62.00.

In other news, Director Daniel W. Campbell sold 4,607 shares of the stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $62.48, for a total value of $287,845.36. Following the completion of the sale, the director now directly owns 63,753 shares of the company’s stock, valued at $3,983,287.44. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, General Counsel D Matthew Dorny sold 7,500 shares of the stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $60.88, for a total value of $456,600.00. Following the completion of the sale, the general counsel now directly owns 52,230 shares of the company’s stock, valued at $3,179,762.40. The disclosure for this sale can be found here. Over the last three months, insiders sold 19,040 shares of company stock valued at $1,188,157. Company insiders own 5.20% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Earnings History for Nu Skin Enterprises (NYSE:NUS)

What are top analysts saying about Nu Skin Enterprises Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Nu Skin Enterprises Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit